Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-273012
Filing Date
2007-12-28
Accepted
2007-12-28 17:09:54
Documents
14
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2216226
2 AMENDED AND RESTATED BYLAWS dex33.htm EX-3.3 78695
3 SUBORDINATION AGREEMENT dex10174.htm EX-10.174 27736
4 ACCENTIA'S 2008 EQUITY INCENTIVE PLAN dex10175.htm EX-10.175 61616
5 EXTENSION LETTER dex10176.htm EX-10.176 3949
6 AGREEMENT & CONSENT dex10177.htm EX-10.177 7729
7 COMMON STOCK PURCHASE WARRANT dex10178.htm EX-10.178 38775
8 CERTIFICATION dex311.htm EX-31.1 5569
9 CERTIFICATION dex312.htm EX-31.2 5346
10 CERTIFICATION dex321.htm EX-32.1 2867
11 CERTIFICATION dex322.htm EX-32.2 2725
12 GRAPHIC g26731img1.jpg GRAPHIC 7653
13 GRAPHIC g26731img_001.jpg GRAPHIC 35791
14 GRAPHIC g26731img_002.jpg GRAPHIC 6823
  Complete submission text file 0001193125-07-273012.txt   2522320
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-51383 | Film No.: 071332546
SIC: 2834 Pharmaceutical Preparations